Sarah Cannon Research — Nashville, Tennessee

Sarah Cannon Research is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Castration Resistant Prostatic Cancer.

Sponsors: Janux Therapeutics, Bliss Biopharmaceutical (Hangzhou) Co., Ltd, Eisai Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research?

Sarah Cannon Research has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research conducted?

Sarah Cannon Research has 3 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Castration Resistant Prostatic Cancer.

Is Sarah Cannon Research accredited by Crixeo Health?

Sarah Cannon Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.